Public Alert: 032/2021 – Palisades Park HIS Issues Voluntary Recall of Miss Slim Due to the Presence of Undeclared Sibutramine
August 20, 2021,
The National Agency for Food and Drug Administration and Control has been informed by the U.S. Food and Drug Administration that Palisades Park, NJ, HIS is voluntarily recalling all lots and all presentations of Miss Slim (10 count & 30 count capsules) to the consumer level.
The recall of Miss Slim was due to the presence of sibutramine in the product.
Miss Slim is marked as a dietary supplement. The presence of sibutramine in Miss Slim renders it an unapproved drug for which safety and efficacy has not been established and therefore subject to a recall.
Products containing sibutramine pose a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Affected Product Details
|Brand||PACK SIZE||Lot No||UPC||Manufacturer|
|Miss Slim||10 counts||All lots||742137605030||Palisades Park, NJ, HIS USA.|
|Miss Slim||30 counts||609728434472|
Healthcare providers’ and Patients’ Action
NAFDAC implores consumers to stop the purchase and use of Miss Slim. Members of the public in possession of the implicated product are implored to handover product to the nearest NAFDAC office.
Patients should contact their physician or healthcare provider if they have experienced any problems that may be related to using the implicated product.
NAFDAC encourages healthcare professionals, consumers and patients to report adverse events related to the use of this product to the nearest NAFDAC office, NAFDAC PRASCOR (20543 TOLLS FREE from all networks) or via firstname.lastname@example.org, E- reporting platforms available on the NAFDAC website or via the Med- safety application available for download on android and IOS stores.